FDA Grants Tentative Approval to First Generic for Antiretroviral Viread
FDA Grants Tentative Approval to First Generic for Antiretroviral Viread
The U.S. Food and Drug Administration has issued a tentative approval for a generic version of Viread (tenofovir disoproxil fumarate), a drug for use in combination with other antiretroviral agents in the treatment of HIV.